Brief: Eagle Pharmaceuticals Files Non-Timely 10-K With US SEC
17/03/2023 12:53
March 17 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS FILES NON-TIMELY 10-K WITH THE U.S.
SEC -
SEC FILING
* EAGLE PHARMACEUTICALS-REQUIRES ADDITIONAL TIME TO COMPLETE
PREPARATION OF FINANCIAL STATEMENTS,ASSESSMENT OF INTERNAL
CONTROL OVER FINANCIAL REPORTING
* EAGLE PHARMACEUTICALS: DOES NOT ANTICIPATE ANY MATERIAL
CHANGES
TO INFORMATION REPORTED ON FORM 8-K FURNISHED BY CO WITH SEC ON
MARCH 13
* EAGLE PHARMACEUTICALS - ERNST & YOUNG, LLP, CO’S
INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM, HAS NOT YET COMPLETED ITS
AUDIT PROCEDURES
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq